Cargando…

Impact of Antiarrhythmic Drugs on the Outcome of Short QT Syndrome

Short QT syndrome (SQTS) is associated with sudden cardiac arrest. There are limited data on the impact of antiarrhythmic drugs on the outcome of SQTS. Materials and Methods: We studied data that describe the clinical outcome of 62 SQTS patients treated with antiarrhythmic drugs, who were recruited...

Descripción completa

Detalles Bibliográficos
Autores principales:	El-Battrawy, Ibrahim, Besler, Johanna, Li, Xin, Lan, Huan, Zhao, Zhihan, Liebe, Volker, Schimpf, Rainer, Lang, Siegfried, Wolpert, Christian, Zhou, Xiaobo, Akin, Ibrahim, Borggrefe, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688193/ https://www.ncbi.nlm.nih.gov/pubmed/31427960 http://dx.doi.org/10.3389/fphar.2019.00771

Ejemplares similares

Long‐Term Follow‐Up of Patients With Short QT Syndrome: Clinical Profile and Outcome
por: El‐Battrawy, Ibrahim, et al.
Publicado: (2018)

Sex-differences in short QT syndrome: A systematic literature review and pooled analysis
por: El-Battrawy, Ibrahim, et al.
Publicado: (2019)

Differences in Short QT Syndrome Subtypes: A Systematic Literature Review and Pooled Analysis
por: Raschwitz, Laura S., et al.
Publicado: (2020)

Effects of Antiarrhythmic Drugs on hERG Gating in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1
por: Huang, Mengying, et al.
Publicado: (2021)

Ionic Mechanisms of Disopyramide Prolonging Action Potential Duration in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1
por: Lan, Huan, et al.
Publicado: (2020)

Antiarrhythmic Effects of Vernakalant in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes from a Patient with Short QT Syndrome Type 1
por: Xu, Qiang, et al.
Publicado: (2022)

Long-Term Follow-Up of Patients with Catecholaminergic Polymorphic Ventricular Arrhythmia
por: Veith, Michael, et al.
Publicado: (2020)

Implantable cardioverter‐defibrillator in Brugada syndrome: Long‐term follow‐up
por: El‐Battrawy, Ibrahim, et al.
Publicado: (2019)

Modeling Short QT Syndrome Using Human‐Induced Pluripotent Stem Cell–Derived Cardiomyocytes
por: El‐Battrawy, Ibrahim, et al.
Publicado: (2018)

The Use of Beta Blockers in Takotsubo Syndrome as Compared to Acute Coronary Syndrome
por: Kummer, Marvin, et al.
Publicado: (2020)

Arrhythmic events in Brugada syndrome patients induced by fever
por: Roterberg, Gretje, et al.
Publicado: (2019)

Impact of Sacubitril/Valsartan on the Long-Term Incidence of Ventricular Arrhythmias in Chronic Heart Failure Patients
por: El-Battrawy, Ibrahim, et al.
Publicado: (2019)

Association of a congenital long QT syndrome type 1 with Takotsubo cardiomyopathy
por: El‐Battrawy, Ibrahim, et al.
Publicado: (2016)

Short‐term and long‐term incidence of stroke in Takotsubo syndrome
por: El‐Battrawy, Ibrahim, et al.
Publicado: (2018)

Short- and Long-Term Incidence of Thromboembolic Events in Takotsubo Syndrome as Compared With Acute Coronary Syndrome
por: El-Battrawy, Ibrahim, et al.
Publicado: (2019)

TRPV1 activation and internalization is part of the LPS-induced inflammation in human iPSC-derived cardiomyocytes
por: Sattler, Katherine, et al.
Publicado: (2021)

Age related differences and outcome of patients with Takotsubo syndrome
por: Huseynov, Aydin, et al.
Publicado: (2017)

Dopamine D1/D5 Receptor Signaling Is Involved in Arrhythmogenesis in the Setting of Takotsubo Cardiomyopathy
por: Huang, Mengying, et al.
Publicado: (2022)

Brugada Syndrome: Different Experimental Models and the Role of Human Cardiomyocytes From Induced Pluripotent Stem Cells
por: Li, Yingrui, et al.
Publicado: (2022)

Takotsubo syndrome and cardiac implantable electronic device therapy
por: El-Battrawy, Ibrahim, et al.
Publicado: (2019)

Regulation of Ion Channel Function in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes by Cancer Cell Secretion Through DNA Methylation
por: Zhong, Rujia, et al.
Publicado: (2022)

Impact of Chronobiological Variation in Takotsubo Syndrome: Prognosis and Outcome
por: El-Battrawy, Ibrahim, et al.
Publicado: (2021)

Hyperthermia Influences the Effects of Sodium Channel Blocking Drugs in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: El-Battrawy, Ibrahim, et al.
Publicado: (2016)

Serum of patients with acute myocardial infarction prevents inflammation in iPSC-cardiomyocytes
por: Sattler, Katherine, et al.
Publicado: (2019)

Nucleoside Diphosphate Kinase B Contributes to Arrhythmogenesis in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes from a Patient with Arrhythmogenic Right Ventricular Cardiomyopathy
por: Buljubasic, Fanis, et al.
Publicado: (2020)

An antiarrhythmic approach to hydroxychloroquine-induced QT prolongation
por: Yetkin, E., et al.
Publicado: (2020)

Long‐term results of combined cardiac contractility modulation and subcutaneous defibrillator therapy in patients with heart failure and reduced ejection fraction
por: Röger, Susanne, et al.
Publicado: (2018)

Lipopolysaccharides induced inflammatory responses and electrophysiological dysfunctions in human-induced pluripotent stem cell derived cardiomyocytes
por: Yücel, Gökhan, et al.
Publicado: (2017)

Impact of ST-segment elevation on the outcome of Takotsubo syndrome
por: Gietzen, Thorsten, et al.
Publicado: (2019)

Low Prevalence of Inappropriate Shocks in Patients With Inherited Arrhythmia Syndromes With the Subcutaneous Implantable Defibrillator Single Center Experience and Long‐Term Follow‐Up
por: Rudic, Boris, et al.
Publicado: (2017)

Further Insights in the Most Common SCN5A Mutation Causing Overlapping Phenotype of Long QT Syndrome, Brugada Syndrome, and Conduction Defect
por: Veltmann, Christian, et al.
Publicado: (2016)

Ion Channel Expression and Characterization in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Zhao, Zhihan, et al.
Publicado: (2018)

Incidence and Prognostic Relevance of Cardiopulmonary Failure in Takotsubo Cardiomyopathy
por: El-Battrawy, Ibrahim, et al.
Publicado: (2017)

Design and Rationale of the Femoral Closure versus Radial Compression Devices Related to Percutaneous Coronary Interventions (FERARI) Study
por: Behnes, Michael, et al.
Publicado: (2015)

Incidence, recurrence and management of electrical storm in Brugada syndrome
por: El-Battrawy, Ibrahim, et al.
Publicado: (2022)

Late Sodium Current Inhibitors as Potential Antiarrhythmic Agents
por: Horváth, Balázs, et al.
Publicado: (2020)

ARumenamides: A novel class of potential antiarrhythmic compounds
por: Abdelsayed, Mena, et al.
Publicado: (2022)

Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting
por: Röger, Susanne, et al.
Publicado: (2018)

Variable Brugada syndrome phenotype severity in a dish: dreams meet reality
por: El-Battrawy, Ibrahim, et al.
Publicado: (2023)

Studying Brugada Syndrome With an SCN1B Variants in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: El-Battrawy, Ibrahim, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cvms0vp57jnn6beq72tt9a10a0